Neuroimaging Cannot Detect Autism by Itself
By MedImaging International staff writers Posted on 12 Nov 2012 |
A biostatistician is warning against advocating the use of brain imaging scans to diagnose autism and emphasized more concentration on performing larger, long-term multicenter studies to identify the biologic mechanisms of the disorder.
The report was published in the November 1, 2012, issue of the journal Nature. “Several studies in the past two years have claimed that brain scans can diagnose autism, but this assertion is deeply flawed,” said Dr. Lange, an associate professor of psychiatry and biostatistics at Harvard Medical School (Boston, MA, USA). “To diagnose autism reliably, we need to better understand what goes awry in people with the disorder. Until its solid biological basis is found, any attempt to use brain imaging to diagnose autism will be futile.”
While advising against current use of brain imaging as a diagnostic approach, Dr. Lange is a strong supporter of using this technology in helping researchers to better clarify autism’s workings. Through the use of several brain imaging modalities, including functional magnetic resonance imaging (MRI), positron emission tomography (PET), and volumetric MRI, Dr. Lange noted that investigators have made significant findings about early brain enlargement in the illness, the role of serotonin in someone with autism, and how individuals with autism focus during social interaction.
“Brain scans have led to these extremely valuable advances, and, with each discovery, we are getting closer to solving the autism pathology puzzle,” said Dr. Lange. “What individuals with autism and their parents urgently need is for us to carry out large-scale studies that lead us to find reliable, sensitive, and specific biological markers of autism with high predictive value that allow clinicians to identify interventions that will improve the lives of people with the disorder.”
Autism and autism spectrum disorder (ASD) are terms typically employed to define a group of complex disorders of brain development. This spectrum characterized, in varying levels, by problems in social interaction, repetitive behaviors, and verbal and nonverbal communication, whose criteria have been revised in the newly proposed Diagnostic and Statistical Manual of Mental Disorders (DSM-5). The occurrence of ASD in the United States has risen 78% in the last 10 years, with the US Centers for Disease Control (Atlanta, GA, USA) estimating that one in 88 children has ASD.
Related Links:
Harvard Medical School
The report was published in the November 1, 2012, issue of the journal Nature. “Several studies in the past two years have claimed that brain scans can diagnose autism, but this assertion is deeply flawed,” said Dr. Lange, an associate professor of psychiatry and biostatistics at Harvard Medical School (Boston, MA, USA). “To diagnose autism reliably, we need to better understand what goes awry in people with the disorder. Until its solid biological basis is found, any attempt to use brain imaging to diagnose autism will be futile.”
While advising against current use of brain imaging as a diagnostic approach, Dr. Lange is a strong supporter of using this technology in helping researchers to better clarify autism’s workings. Through the use of several brain imaging modalities, including functional magnetic resonance imaging (MRI), positron emission tomography (PET), and volumetric MRI, Dr. Lange noted that investigators have made significant findings about early brain enlargement in the illness, the role of serotonin in someone with autism, and how individuals with autism focus during social interaction.
“Brain scans have led to these extremely valuable advances, and, with each discovery, we are getting closer to solving the autism pathology puzzle,” said Dr. Lange. “What individuals with autism and their parents urgently need is for us to carry out large-scale studies that lead us to find reliable, sensitive, and specific biological markers of autism with high predictive value that allow clinicians to identify interventions that will improve the lives of people with the disorder.”
Autism and autism spectrum disorder (ASD) are terms typically employed to define a group of complex disorders of brain development. This spectrum characterized, in varying levels, by problems in social interaction, repetitive behaviors, and verbal and nonverbal communication, whose criteria have been revised in the newly proposed Diagnostic and Statistical Manual of Mental Disorders (DSM-5). The occurrence of ASD in the United States has risen 78% in the last 10 years, with the US Centers for Disease Control (Atlanta, GA, USA) estimating that one in 88 children has ASD.
Related Links:
Harvard Medical School
Latest Nuclear Medicine News
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
- Combining Advanced Imaging Technologies Offers Breakthrough in Glioblastoma Treatment
- New Molecular Imaging Agent Accurately Identifies Crucial Cancer Biomarker
- New Scans Light Up Aggressive Tumors for Better Treatment
- AI Stroke Brain Scan Readings Twice as Accurate as Current Method
- AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer
- New Imaging Agent to Drive Step-Change for Brain Cancer Imaging
- Portable PET Scanner to Detect Earliest Stages of Alzheimer’s Disease
Channels
Radiography
view channel
AI Improves Early Detection of Interval Breast Cancers
Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read moreUltrasound
view channel.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read moreNuclear Medicine
view channel
Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read moreGeneral/Advanced Imaging
view channel
AI-Based CT Scan Analysis Predicts Early-Stage Kidney Damage Due to Cancer Treatments
Radioligand therapy, a form of targeted nuclear medicine, has recently gained attention for its potential in treating specific types of tumors. However, one of the potential side effects of this therapy... Read more
CT-Based Deep Learning-Driven Tool to Enhance Liver Cancer Diagnosis
Medical imaging, such as computed tomography (CT) scans, plays a crucial role in oncology, offering essential data for cancer detection, treatment planning, and monitoring of response to therapies.... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more